Thyroid cancer is a relatively rare cancer, but with the advances in modern medical technology, early detection and treatment of thyroid cancer is becoming more and more secure, and many patients have access to good prognosis through timely treatment. Therefore, it is also often referred to as the “lucky tumor”.
What is thyroid cancer?
The thyroid is an important endocrine gland in the neck and is primarily responsible for synthetic thyroid hormones and for regulating metabolism in the human body. Thyroid cancer refers to malignant tumours in the thyroid, the most common types of which include thyroid breast cancer, thyroid filtration blister cancer, thyroid marrow cancer and thyroid undivalid cancer.
Of these, thyroid breast cancer is the most common type, accounting for about 80 per cent of all thyroid cancer. It is usually slow to grow and most patients have no visible symptoms at an early stage, so early detection is essential.
The spread of thyroid cancer
The distribution of thyroid cancer is based on the size of the tumor, its transfer and the age of the patient. The most common phased system is the TNM phased system, which includes the following:
T (tumour): Describe the size of the original tumour and whether it affects the surrounding tissue. N (lymph nodes): Is there a lymph nodes transfer and how big the lymph nodes are? M (Transfer): Is there a remote transfer to which organs.
The stratification of thyroid cancer helps doctors to determine the severity of the disease and to guide the choice of treatment strategies.
Detection and early diagnosis of thyroid breast cancer
Thyroid breast cancer is growing slowly and most patients may not have visible symptoms at an early stage. Common symptoms include a swollen neck, a sense of oppression, or infirmity when swallowed and breathing. But these symptoms are not unique and are often easily ignored.
Early screening and periodic medical examinations are therefore particularly important. Anomalous changes in the thyroid, such as knots or swellings, can be detected through neck ultrasound, which can facilitate early detection of potential tumours. In addition, regular screening is particularly necessary for groups with family history of thyroid cancer or chronic exposure to radiation.
Treatment of thyroid breast cancer
The treatment of thyroid breast cancer consists mainly of surgery, radioiodine therapy (RAI) and target-oriented treatment.
Surgical treatment: The treatment of thyroid breast cancer is generally based on surgery, most commonly through thyroid removal, which may require the removal of the entire thyroid or part of the thyroid, depending on the size and distribution of the tumor.
Radioiodine Treatment (RAI): After surgery, some patients may receive radioiodine treatment. This treatment uses the characteristics of radioiodine, which can help to reduce the risk of recurrence by targeting or transferring cancer cells that remain.
Targeting treatment and hormone substitution treatment: Targeting treatment and hormone substitution treatment are also common treatment options for a small number of patients who are unable to undergo surgery, or for patients with post-operative relapse.
Early discovery, science therapy.
Early diagnosis of thyroid cancer, especially thyroid breast cancer, is critical. This “lucky tumor” can be detected and effectively treated as soon as possible through regular medical examinations and screening of high-risk groups. Despite its slow growth, cancer can spread and make treatment more difficult if the best treatment is missed. Early detection and scientific treatment are therefore key to combating thyroid cancer.
For thyroid cancer patients, scientific treatment and long-term follow-up management can significantly improve the quality of life and enable the vast majority of patients to achieve long-term survival. As long as we are able to focus on regular examinations, early diagnosis and the selection of appropriate treatments, the incidence and prognosis of thyroid cancer will increase significantly.
Thyroid cancer
